ABT Abbott Laboratories
Price (delayed)
$131.69
Market cap
$228.39B
P/E Ratio
17.17
Dividend/share
$2.24
EPS
$7.67
Enterprise value
$234.55B
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott
Highlights
Abbott Laboratories's net income has surged by 134% YoY and by 132% QoQ
The EPS has soared by 134% YoY and by 132% from the previous quarter
Key stats
What are the main financial stats of ABT
Market
Valuations
Earnings
Shares outstanding
1.73B
Market cap
$228.39B
Enterprise value
$234.55B
Price to earnings (P/E)
17.17
Price to book (P/B)
4.77
Price to sales (P/S)
5.46
EV/EBIT
30.98
EV/EBITDA
21.74
EV/Sales
5.59
Revenue
$41.95B
Gross profit
$23.24B
Operating income
$6.83B
Net income
$13.4B
EBIT
$7.57B
EBITDA
$10.79B
Free cash flow
$6.35B
Per share
Balance sheet
Liquidity
EPS
$7.67
EPS diluted
$7.64
Free cash flow per share
$3.65
Book value per share
$27.62
Revenue per share
$24.11
TBVPS
$29.69
Total assets
$81.41B
Total liabilities
$33.51B
Debt
$14.13B
Equity
$47.9B
Working capital
$9.5B
Debt to equity
0.29
Current ratio
1.67
Quick ratio
1.05
Net debt/EBITDA
0.57
Margins
Efficiency
Dividend
EBITDA margin
25.7%
Gross margin
55.4%
Net margin
31.9%
Operating margin
16.3%
Return on assets
17.8%
Return on equity
32.2%
Return on invested capital
20.1%
Return on capital employed
11.3%
Return on sales
18.1%
Dividend yield
1.7%
DPS
$2.24
Payout ratio
29.2%
ABT stock price
How has the Abbott Laboratories stock price performed over time
Intraday
-0.72%
1 week
4.85%
1 month
-4.58%
1 year
17.49%
YTD
16.43%
QTD
-0.72%
Financial performance
How have Abbott Laboratories's revenue and profit performed over time
Revenue
$41.95B
Gross profit
$23.24B
Operating income
$6.83B
Net income
$13.4B
Gross margin
55.4%
Net margin
31.9%
Abbott Laboratories's net income has surged by 134% YoY and by 132% QoQ
Abbott Laboratories's net margin has surged by 128% QoQ and by 123% YoY
The revenue has grown by 4.6% YoY
The gross profit has increased by 5% year-on-year
Growth
What is Abbott Laboratories's growth rate over time
Valuation
What is Abbott Laboratories stock price valuation
P/E
17.17
P/B
4.77
P/S
5.46
EV/EBIT
30.98
EV/EBITDA
21.74
EV/Sales
5.59
The EPS has soared by 134% YoY and by 132% from the previous quarter
ABT's P/E is 49% below its 5-year quarterly average of 33.6 and 41% below its last 4 quarters average of 29.3
ABT's equity is up by 23% year-on-year and by 20% since the previous quarter
ABT's price to book (P/B) is 9% lower than its 5-year quarterly average of 5.3 but 2.1% higher than its last 4 quarters average of 4.7
ABT's P/S is 17% above its last 4 quarters average of 4.7 and 12% above its 5-year quarterly average of 4.9
The revenue has grown by 4.6% YoY
Efficiency
How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has surged by 128% YoY and by 125% QoQ
ABT's ROE has soared by 119% from the previous quarter and by 113% YoY
The ROIC has contracted by 4.7% YoY and by 3.8% from the previous quarter
Dividends
What is ABT's dividend history
DPS
$2.24
Dividend yield
1.7%
Payout ratio
29.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Abbott Laboratories financials performed over time
The total assets is 143% more than the total liabilities
The total assets has grown by 11% YoY and by 9% from the previous quarter
ABT's quick ratio is up by 5% since the previous quarter and by 5% year-on-year
Abbott Laboratories's debt is 71% lower than its equity
Abbott Laboratories's debt to equity has decreased by 24% YoY and by 22% from the previous quarter
ABT's equity is up by 23% year-on-year and by 20% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.